Thank you for visiting Ohio.com. We noticed you are using an outdated browser that may not give you the best user experience. We recommend current browser versions of Google’s Chrome, Microsoft’s Edge, Mozilla’s Firefox. For more specific information on how to update your browser --Click Here or visit your browser’s website.
This image provided by the National Institutes of Health, shows red blood cells in a patient with sickle cell disease at the National Institutes of Health Clinical Center in Bethesda, Md. A small but promising government study by National Institutes of Health found that bone marrow transplants can reverse severe sickle cell disease in adults. Results were published Tuesday in the Journal of the American Medical Association. (AP Photo/National Institutes of Health)
WASHINGTON: Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.